Cipla Q3 Profit Dips 57% Due to Lanreotide Production Halt

Cipla, a company that makes medicines, had a big drop in its profit for the third quarter of 2025.

This happened because they had to stop making a medicine called Lanreotide, which is used to treat a growth hormone disorder.

The stop happened because of some issues found by a US health authority at their partner's factory in Greece.

The company's leaders said they are working to fix the problems and expect to start making Lanreotide again in the first half of 2027.

They also mentioned that they have other new medicines coming out to help make up for the loss.

Cipla made a lot of money from other medicines and in different parts of the world, like India and North America.

They also spent money on researching and developing new medicines.